At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 37 enrolled
Drug / intervention
Aripiprazole IM Depotdrug
Likely dose
Aripiprazole IM Depot 400 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-label, Randomized, Parallel Arm, Bioavailability Trial of Aripiprazole IM Depot Administered in the Deltoid or Gluteal Muscle in Adult Subjects With Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc.·interventional·Posted Jul 20, 2012·Updated Jul 31, 2014
In Brief
A Phase 1 clinical trial evaluating Aripiprazole IM Depot for Schizophrenia. Completed, enrolled 37 participants across 6 sites.
Detailed Summary
The purpose of this study is to determine whether aripiprazole injection into the shoulder or the buttocks produces similar effects in the body
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2012
First PostedJul 2012
Primary CompletionApr 2013
TodayJul 2026
First PostedJul 20, 2012
Enrollment StartMay 1, 2012
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 14.0 years ago
Interventions
Aripiprazole IM Depotdrug
One injection of 400 mg aripiprazole IM depot